Arcutis Biotherapeutics (ARQT) Total Debt (2021 - 2025)
Historic Total Debt for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Q3 2025 value amounting to $108.5 million.
- Arcutis Biotherapeutics' Total Debt fell 4697.27% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.5 million, marking a year-over-year decrease of 4697.27%. This contributed to the annual value of $107.2 million for FY2024, which is 4687.63% down from last year.
- According to the latest figures from Q3 2025, Arcutis Biotherapeutics' Total Debt is $108.5 million, which was down 4697.27% from $108.0 million recorded in Q2 2025.
- Arcutis Biotherapeutics' 5-year Total Debt high stood at $204.6 million for Q3 2024, and its period low was $72.4 million during Q4 2021.
- In the last 5 years, Arcutis Biotherapeutics' Total Debt had a median value of $197.3 million in 2022 and averaged $153.5 million.
- In the last 5 years, Arcutis Biotherapeutics' Total Debt soared by 17335.04% in 2022 and then plummeted by 4698.49% in 2025.
- Arcutis Biotherapeutics' Total Debt (Quarter) stood at $72.4 million in 2021, then soared by 173.35% to $197.8 million in 2022, then grew by 2.04% to $201.8 million in 2023, then tumbled by 46.88% to $107.2 million in 2024, then rose by 1.21% to $108.5 million in 2025.
- Its Total Debt stands at $108.5 million for Q3 2025, versus $108.0 million for Q2 2025 and $107.6 million for Q1 2025.